Neuroprotection with Erythropoietin Administration Following Controlled Cortical Impact Injury in Rats
Open Access
- 1 August 2007
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 322 (2) , 789-794
- https://doi.org/10.1124/jpet.107.119628
Abstract
This study was designed to determine the effect of erythropoietin (Epo) on cerebral blood flow (CBF), nitric oxide (NO) concentration, and neurological outcome after traumatic brain injury. In one experiment, the hemodynamic effects of Epo were determined after controlled cortical impact injury (CCII) by measuring mean arterial pressure, intracranial pressure, CBF using laser Doppler flowmetry, and brain tissue NO concentrations using an NO electrode. In total, 41 rats were given either Epo (5000 U/kg) or saline s.c. 3 days before injury. In animals pretreated with saline, l-arginine but not d-arginine administration resulted in a significant increase in tissue NO concentrations and an improvement in CBF at the impact site. Likewise, in animals pretreated with Epo, l-arginine but not d-arginine given postinjury increased brain tissue NO concentrations and increased CBF. In another experiment, 74 rats underwent CCII (3-mm deformation, velocity 5 m/s), and they were given saline or Epo 5000 U/kg s.c. at 5 min, 1 h, 3 h, 6 h, 9 h, or 12 h postinjury. The contusion volume and cell counts of viable neurons in the CA1 and CA3 regions of the hippocampus were assessed at 2 weeks postinjury. The contusion volume was significantly reduced at 5 min, 1 h, 3 h, and 6 h postinjury Epo administration. The neuron density in the CA1 and CA3 region of the hippocampus was increased at 1, 3, and 6 h after injury. These data demonstrate the neuroprotective effects of Epo in traumatic injury, and the effects are optimal when Epo is given with in 6 h of injury.Keywords
This publication has 39 references indexed in Scilit:
- Neonatal Hypoxia/Ischemia Is Associated With Decreased Inflammatory Mediators After Erythropoietin AdministrationStroke, 2005
- Erythropoietin is neuroprotective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injuryThe FASEB Journal, 2005
- The Role of Endothelial Nitric Oxide Synthase in the Cerebral Hemodynamics after Controlled Cortical Impact Injury in MiceJournal of Neurotrauma, 2003
- Critical Role for Akt1 in the Modulation of Apoptotic Phosphatidylserine Exposure and Microglial ActivationMolecular Pharmacology, 2003
- Beyond erythropoiesis: Novel applications for recombinant human erythropoietinSeminars in Hematology, 2001
- Effect of 1‐week treatment with erythropoietin on the vascular endothelial function in anaesthetized rabbitsBritish Journal of Pharmacology, 2001
- Marked reduction in the incidence of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation with CD34+ positive selectionBone Marrow Transplantation, 2001
- Exposure of endothelial cells to recombinant human erythropoietin induces nitric oxide synthase activityKidney International, 2000
- A Potential Role for Erythropoietin in Focal Permanent Cerebral Ischemia in MiceJournal of Cerebral Blood Flow & Metabolism, 1999
- Secondary Insults Increase Injury after Controlled Cortical Impact in RatsJournal of Neurotrauma, 1996